Ozempic could face Medicare drug price negotiations next
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. George Frey | ReutersOzempic, the blockbuster diabetes treatment from Novo Nordisk, could be next in line in the price...